Universal Immunisation Programme (India)

Universal Immunisation Programme (India)
Name	Universal Immunisation Programme (India)
Launched	1978
Administered by	Ministry of Health and Family Welfare
Headquarters	New Delhi
Status	Active

Universal Immunisation Programme (India) is a national public health initiative delivering vaccines to infants, children, pregnant women and high‑risk groups across India. Established to reduce morbidity and mortality from vaccine‑preventable diseases, the programme interfaces with state health departments, international agencies and research institutions to plan, procure and monitor vaccine delivery.

History and development

The programme began in 1978 under the aegis of the Ministry of Health and Family Welfare and expanded through policy reforms influenced by agencies such as the World Health Organization, United Nations Children's Fund, and the World Bank. During the 1980s and 1990s, coordination with the National Centre for Disease Control, Indian Council of Medical Research, and state bodies like the Karnataka State Health Department guided cold chain development and training. Major turns included the introduction of the Pulse Polio campaign in partnership with the Rotary International and the later integration of new vaccines following recommendations from the National Technical Advisory Group on Immunization (NTAGI), the Gavi, the Vaccine Alliance, and the Global Polio Eradication Initiative.

Objectives and scope

Primary objectives include reducing infant and under‑five mortality through immunisation against diseases listed by the World Health Organization, achieving equity in access across rural districts like Malkangiri and urban centres such as Mumbai, and meeting international targets framed by the Sustainable Development Goals. The scope encompasses routine immunisation at primary health centres, outreach in tribal districts like Bastar, and periodic campaigns in partnership with entities including the Indian Red Cross Society and the National Rural Health Mission.

Vaccines and schedule

The schedule has evolved to include vaccines against diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, tuberculosis, Haemophilus influenzae type b, and newer introductions like rotavirus and inactivated poliovirus vaccine. Implementation of the Measles–Rubella vaccine campaign and phased roll‑outs of the Human papillomavirus vaccine were guided by expert committees such as the National Technical Advisory Group on Immunization (NTAGI) and trials coordinated by the Indian Council of Medical Research. The schedule aligns with recommendations from the World Health Organization and adapts to evidence from institutions like the All India Institute of Medical Sciences and the Christian Medical College, Vellore.

Implementation and delivery mechanisms

Delivery uses an infrastructure of primary health centres, community health centres, and subcentres integrated with programmes like the National Health Mission and supported by cold chain logistics from manufacturers such as Bharat Biotech and Serum Institute of India. Human resources include auxiliary nurse midwives coordinated through state directorates like the Tamil Nadu Health Directorate and training provided by institutions such as the Public Health Foundation of India. Vaccine procurement and financing have involved partners including the Gavi, the Vaccine Alliance, the World Bank, and bilateral donors, while monitoring uses systems developed by the National Informatics Centre and reports from bodies such as the Registrar General of India.

Coverage, monitoring, and evaluation

Coverage data are collected by the National Family Health Survey, the District Level Household and Facility Survey, and administrative reporting to the Ministry of Health and Family Welfare, with evaluation studies undertaken by the Indian Council of Medical Research and academic groups at universities like Jawaharlal Nehru University and University of Delhi. Monitoring includes cold chain assessments by the Central Drugs Standard Control Organization and vaccine safety surveillance coordinated with the Pharmacovigilance Programme of India and international partners like the World Health Organization.

Challenges and criticisms

Challenges cited by researchers at institutions such as the Public Health Foundation of India and activists including those associated with the People's Health Movement include gaps in coverage in districts like Koraput, vaccine hesitancy documented in states such as Punjab, logistics failures in remote areas like the Andaman and Nicobar Islands, and funding uncertainties flagged by analyses from the World Bank and Economic Survey of India. Criticisms have addressed cold chain breaches reported by the Comptroller and Auditor General of India, equity concerns raised by civil society groups, and debates over introduction of new vaccines discussed in parliamentary committees and in peer‑reviewed literature from journals associated with the Indian Council of Medical Research.

Impact and outcomes

The programme has contributed to dramatic declines in diseases such as polio—with India certified polio‑free by the World Health Organization—and reductions in measles and neonatal tetanus as documented by the Registrar General of India and the National Family Health Survey. Studies by the Indian Council of Medical Research, the Public Health Foundation of India, and academic hospitals like Christian Medical College, Vellore have quantified mortality reductions and cost‑effectiveness, while ongoing surveillance by the National Centre for Disease Control and international partners including the World Health Organization continue to guide policy and strategy.

Category:Health programmes in India Category:Vaccination programs